Investor Overview

Webcast ImageWebcast
Verastem Inc Fourth Quarter and Full Year 2016 Financial Results Conference Call  (Live)
03/23/17 at 4:30 p.m. ET
Verastem Inc Fourth Quarter and Full Year 2016 Financial Results Conference Call
Thursday, March 23, 2017 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Verastem Inc at Oppenheimer 27th Annual Healthcare Conference (Replay)
03/21/17 at 2:10 p.m. ET
Verastem Inc at Oppenheimer 27th Annual Healthcare Conference
Tuesday, March 21, 2017 2:10 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Verastem, Inc. (NASDAQ:VSTM) is a biopharmaceutical company focused on discovering and developing drugs to improve outcomes for patients with cancer. Verastem’s product candidates seek to treat cancer by targeting malignant cells both directly and through modulation of the tumor microenvironment. The Company is currently developing duvelisib, a dual inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, which has successfully met its primary endpoint in a Phase 2 study in refractory indolent Non-Hodgkin’s Lymphoma (iNHL) and is currently being evaluated in a Phase 3 registration trial in patients with relapsed/refractory chronic lymphocytic leukemia (CLL). Other clinical product candidates include focal adhesion kinase (FAK) inhibitors defactinib and VS-4718, and dual PI3K/mTOR inhibitor VS-5584. Defactinib is currently being evaluated in three separate clinical collaborations in combination with immunotherapeutic agents for the treatment of several different cancer types, including pancreatic, ovarian and non-small cell lung cancer, and mesothelioma.
Stock Quote
VSTM (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$1.45
Change (%) Stock is Down 0.09 (5.84%)
Volume371,814
Data as of 03/22/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News More >>
DateTitle 
03/16/17Verastem to Host Conference Call on March 23rd to Discuss Fourth Quarter and Full-Year 2016 Financial Results and Recent Highlights
BOSTON--(BUSINESS WIRE)--Mar. 16, 2017-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced that the Company will host a conference call and webcast on Thursday, March 23, 2017 at 4:30 p.m. Eastern Time to discuss corporate updates and financial results for the fourth quarter and year ended December 31, 2016. The call can be accessed by dialing (877) 341-5660 (U.S. and Canada) or (315... 
Printer Friendly Version
03/15/17Verastem to Present at the Oppenheimer 27th Annual Healthcare Conference
BOSTON--(BUSINESS WIRE)--Mar. 15, 2017-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced that the company will present at the Oppenheimer 27th Annual Healthcare Conference on Tuesday, March 21st at 2:10 p.m. ET at the Westin Grand Central in New York City. A live audio webcast of the presentation will be available on the company’s website at www.verastem.com. An archived pre... 
Printer Friendly Version
03/07/17Verastem to Present at the 29th Annual ROTH Conference
BOSTON--(BUSINESS WIRE)--Mar. 7, 2017-- Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer, today announced that the company will present at the 29th Annual ROTH Conference on Monday, March 13th at 4:00 p.m. PT at the Ritz Carlton in Dana Point, CA. A live audio webcast of the presentation will be available on the company’s website at www.verastem.com. An archived presentation will be available for 9... 
Printer Friendly Version
02/07/17Verastem to Present at 19th Annual BIO CEO & Investor Conference
BOSTON--(BUSINESS WIRE)--Feb. 7, 2017-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced that the company will present at the 19th Annual BIO CEO & Investor Conference on Tuesday, February 14th at 9:00 a.m. ET at the Waldorf Astoria Hotel in New York City. A live audio webcast of the presentation will be available on the company’s website at www.verastem.com. An archived ... 
Printer Friendly Version
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Verastem Inc posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.